EICHOR ● Active Not Recruiting

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Condition: Advanced Solid Tumor · Sponsor: DualityBio Inc.

PhasePhase 1/Phase 2

Planned participants1123

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1305/BNT325 in subjects with advanced solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (93)

Site 139	Bullhead City, Arizona, United States	—
Site 103	Cerritos, California, United States	—
Site 136	La Jolla, California, United States	—
Site 127	Los Angeles, California, United States	—
Site 133	Los Angeles, California, United States	—
Site 108	Los Angeles, California, United States	—
Site 131	Washington D.C., District of Columbia, United States	—
Site 122	Coral Springs, Florida, United States	—
Site 142	Hialeah, Florida, United States	—
Site 114	Margate, Florida, United States	—
Site 120	Miami, Florida, United States	—
Site 126	Ocala, Florida, United States	—

+ 81 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →